Extending separate ceiling price of IV Fluids in special packaging

8210 GI/202 4 (1) EXTRAORDINARY PART II —Section 3 —Sub-section ( ii) PUBLISHED BY AUTHORITY (1) (2) (3) No. 5090] NEW DELHI, THURSDAY , DECEMBER 19, 2024 /AGRAHAYANA 28 , 194 6 CG-DL-E-19122024-259538 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals ) (NATIONAL PHARMACEUTICAL PRICI NG AUTHORITY ) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5499(E). —The National Pharmaceutical Pricing Authority’s Order No. 1552(E) dated 26th March , 2024 read with S.O. 2293(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation packs of I.V. fluids (non -Glass with special features) is henceforth to be read with the following additions: (1) Sl. No. 28 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Prod uct/ Brand Name (1) (2) (3) 28. M/s Jedux Parenteral Private Limited (note g1 below) JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS (2) Clause (g1) is added after clause (g) & shall be read as follows: “(g1) In case of M/s Jedux Parenteral Private Limite d mentioned in Sl. No. 28 of Table B, only the prices of the formulations specified in Sl. No. 1,2,3,4,5,7 & 8 of Table A are applicable” [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA -Div.-II] MAHAVEER SAINI , Dy. Director (1) (2) (3) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5 500(E).—The National Pharmaceutical Pricing Authority’s Order No. 1553(E) dated 26th March , 2024 read with S.O. 2292(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulations as specified therein is henceforth to be read with the foll owing additions: (1) Sl. No. 21 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/Brand Name (1) (2) (3) 21. M/s Jedux Parenteral Private Limited (note e2 below) JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS (2) Clause (e2) i s added after clause (e1) & shall be read as follows: “(e2) In case of M/s Jedux Parenteral Private Limited mentioned in Sl. No. 21 of Table B, only the prices of the formulations specified in Sl. No. 3 & 4 of Table A are applicable.” [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA -Div.-II] MAHAVEER SAINI, Dy. Director (1) (2) (3) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5 501(E).—The National Pharmaceutical Pricing Authority’s Order No. 155 6(E) dated 26th March 2024 read with S.O. 2288(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of the scheduled formulation as specified therein is henceforth to be read with the following additi ons: (1) Sl. No. 7 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product /Brand Name (1) (2) (3) 7. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPP A-Div.-II] MAHAVEER SAINI, Dy. Director (1) (2) (3) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5 502(E).—The National Pharmaceutical Pricing Authority’s Order No 2286(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation as specified therein, in pursuance to the decision taken in 128th meeting of the Authority, is henceforth to be read with the following additions: (1) Sl. No. 2 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/ Brand Name (1) (2) (3) 2. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA -Div.-II] MAHAVEER SAINI, Dy. Director (1) (2) (3) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5 503(E).—The National Pharmaceutical Pricing Authority’s Order No. 1555(E) dated 26th March 2024 read with S.O. 2291(E) dated 14th June 2024, published in the Gazette of Ind ia, Extraordinary, related to ceiling price fixation of the scheduled formulation as specified therein is henceforth to be read with the following additions: (1) Sl. No. 9 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/Brand N ame (1) (2) (3) 9. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA -Div.-II] MAH AVEER SAINI, Dy. Director (1) (2) (3) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5 504(E).—The National Pharmaceutical Pricing Authority’s Order No. 1557(E) dated 26th March 2024 read with S.O. 2287 (E) dated 1 4th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation as specified therein is henceforth to be read with the following additions: (1) Sl. No. 8 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/ Brand Name (1) (2) (3) 8. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA -Div.-II] MAHAVEER SAINI, Dy. Director (1) (2) (3) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5 505(E).—The National Pharmaceutical Pricing Authority’s Order No 2289(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation as specified therein is henceforth to be read with the following additions: (1) Sl. No. 2 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/ Brand Name (1) (2) (3) 2. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA -Div.-II] MAHAVEER SAINI, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi -110064 and Published by the Controller of Publications, Delhi -110054.